<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36137590</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1399-3003</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The European respiratory journal</Title><ISOAbbreviation>Eur Respir J</ISOAbbreviation></Journal><ArticleTitle>Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2200970</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/13993003.00970-2022</ELocationID><Abstract><AbstractText Label="BACKGROUND">Autoimmunity has been reported in patients with severe coronavirus disease 2019 (COVID-19). We investigated whether anti-nuclear/extractable-nuclear antibodies (ANAs/ENAs) were present up to a year after infection, and if they were associated with the development of clinically relevant post-acute sequalae of COVID-19 (PASC) symptoms.</AbstractText><AbstractText Label="METHODS">A rapid-assessment line immunoassay was used to measure circulating levels of ANAs/ENAs in 106 convalescent COVID-19 patients with varying acute phase severities at 3, 6 and 12&#x2005;months post-recovery. Patient-reported fatigue, cough and dyspnoea were recorded at each time point. Multivariable logistic regression model and receiver operating curves were used to test the association of autoantibodies with patient-reported outcomes and pro-inflammatory cytokines.</AbstractText><AbstractText Label="RESULTS">Compared to age- and sex-matched healthy controls (n=22) and those who had other respiratory infections (n=34), patients with COVID-19 had higher detectable ANAs at 3&#x2005;months post-recovery (p&lt;0.001). The mean number of ANA autoreactivities per individual decreased between 3 and 12&#x2005;months (from 3.99 to 1.55) with persistent positive titres associated with fatigue, dyspnoea and cough severity. Antibodies to U1-snRNP and anti-SS-B/La were both positively associated with persistent symptoms of fatigue (p&lt;0.028, area under the curve (AUC) 0.86) and dyspnoea (p&lt;0.003, AUC=0.81). Pro-inflammatory cytokines such as tumour necrosis factor (TNF)-&#x3b1; and C-reactive protein predicted the elevated ANAs at 12&#x2005;months. TNF-&#x3b1;, D-dimer and interleukin-1&#x3b2; had the strongest association with symptoms at 12&#x2005;months. Regression analysis showed that TNF-&#x3b1; predicted fatigue (&#x3b2;=4.65, p=0.004) and general symptomaticity (&#x3b2;=2.40, p=0.03) at 12&#x2005;months.</AbstractText><AbstractText Label="INTERPRETATION">Persistently positive ANAs at 12&#x2005;months post-COVID are associated with persisting symptoms and inflammation (TNF-&#x3b1;) in a subset of COVID-19 survivors. This finding indicates the need for further investigation into the role of autoimmunity in PASC.</AbstractText><CopyrightInformation>Copyright &#xa9;The authors 2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Son</LastName><ForeName>Kiho</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamil</LastName><ForeName>Rameen</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chowdhury</LastName><ForeName>Abhiroop</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Mathematics and Statistics, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Equal contribution.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukherjee</LastName><ForeName>Manan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Mathematics and Statistics, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Equal contribution.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venegas</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyasaki</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kayla</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Zil</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salter</LastName><ForeName>Brittany</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuen</LastName><ForeName>Agnes Che Yan</ForeName><Initials>ACY</Initials><AffiliationInfo><Affiliation>Department of Medicine and Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Kevin Soon-Keen</ForeName><Initials>KS</Initials><Identifier Source="ORCID">0000-0002-8960-6900</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cowbrough</LastName><ForeName>Braeden</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radford</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Firestone Institute for Respiratory Health, The Research Institute of St Joes, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chynna</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Firestone Institute for Respiratory Health, The Research Institute of St Joes, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kjarsgaard</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Firestone Institute for Respiratory Health, The Research Institute of St Joes, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dvorkin-Gheva</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7295-7440</Identifier><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Quan-Zhen</ForeName><Initials>QZ</Initials><AffiliationInfo><Affiliation>Department of Immunology and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waserman</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryerson</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Medicine and Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>Parameswaran</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Terence</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-0412-6538</Identifier><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balakrishnan</LastName><ForeName>Narayanaswamy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Mathematics and Statistics, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazy</LastName><ForeName>Ishac</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowdish</LastName><ForeName>Dawn M E</ForeName><Initials>DME</Initials><Identifier Source="ORCID">0000-0001-6823-2957</Identifier><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Firestone Institute for Respiratory Health, The Research Institute of St Joes, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svenningsen</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlsten</LastName><ForeName>Chris</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2455-6575</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukherjee</LastName><ForeName>Manali</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7924-7211</Identifier><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada mukherj@mcmaster.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Respir J</MedlineTA><NlmUniqueID>8803460</NlmUniqueID><ISSNLinking>0903-1936</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000974">Antibodies, Antinuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur Respir J. 2023 Jan 12;61(1):2202272. doi: 10.1183/13993003.02272-2022</RefSource><PMID Version="1">36634924</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="Y">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000974" MajorTopicYN="N">Antibodies, Antinuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflict of interest: Manali Mukherjee is supported by early investigator award from Canadian Institutes of Health Research (CIHR) and Canadian Asthma Allergy and Immunology Foundation (CAAIF); and reports grants from CIHR and Methapharm Specialty Pharmaceuticals, personal fees from AstraZeneca and GlaxoSmithKline, consultant fees from Novartis, outside the submitted work. S. Svenningsen reports grants from Cyclomedica, personal fees from Arrowhead Pharmaceuticals, honorarium for lectures from AZ, Novartis and Polarean, outside the submitted work. S. Waserman reports grants and consulting fees from Alk Abello and CSL Behring, grants from Canadian Allergy, Asthma, and Immunology Foundation, Aimmune and Takeda, personal and consulting fees from AZ, GSK, Sanofi, Medexus, Miravo Health and Bausch Lomb, consulting fees from Novartis, Pfizer and AbbVie, outside of the submitted work; and is chairperson of an advisory board for Siolta, president for CAAIF, board of directors for Asthma Canada, and medical advisor for Food Allergy Canada. P. Nair reports grants and personal fees from AZ, Teva and Sanofi, personal fees from GSK, Equillium and Arrowhead pharma, grants from Foresee and Cyclomedica, outside the submitted work. N. Balakrishnan reports grants from Natural Sciences and Engineering Research Council of Canada, outside the submitted work. D.M.E. Bowdish reports grants from COVID-19 Immunity Task Force/Public Health Agency of Canada, grants from National Science and Engineering Research Council (NSERC), grants from Canadian Institutes of Health Research, personal fees from AZ Mexico, personal fees for invited presentations from academic institutions, outside the submitted work; and is on the board of directors for Lung Health Foundation, and has been an expert testimony witness for the Government of Canada. K. Son, R. Jamil, A. Chowdhury, Manan Mukherjee, C. Venegas, K. Miyasaki, K. Zhang, Z. Patel, B. Salter, A.C.Y. Yuen, K.S-K. Lau, B. Cowbrough, K. Radford, C. Huang, M. Kjarsgaard, A. Dvorkin-Gheva, J. Smith, Q-Z. Li, C.J. Ryerson, T. Ho, I. Nazy and C. Carlsten have nothing to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>22</Day><Hour>20</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36137590</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pii">13993003.00970-2022</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>